Wednesday, November 01, 2017 9:01:44 PM
When you look at the Arch Company presentation page 26
https://content.equisolve.net/archtherapeutics/media/c6dc3c52a4e0458fae43779086460ea0.pdf
they show the Potential external applications for but a few of the 200+ applications for AC5
in JUST the USA:
Adhesions Opportunity $ 1 to $ 2 Billion
GI Sealant Opportunity $ .5 to $ 1 Billion
Burns Opportunity $ 1 Billion
Shown previously
Pressure Ulcers Opportunity $ 2 Billion (2.5 million people costing $ 10 Billion in USA)
Foot Ulcers Opportunity $ 1 to $ 2 Billion
These are not small target markets for external applications do you agree? BTW the profit margins are extremely high---extremely high !!
Do you follow Dr. KSS MD PHD? His PHD in in Molecular
Biology of Coagulation Regulation. Right in Arch's field !!
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM
Snakes & Lattes Opens Pop-Up Location at The Wellington Market in Toronto: A New Destination for Fun and Games - Thanks 'The Well', PepsiCo, Indie Pale House & All Sponsors & Partners for Their Commitment & Assistance Throughout The Process • FUNN • Jun 13, 2024 8:18 AM
HealthLynked Introduces Innovative Online Medical Record Request Form Using DocuSign • HLYK • Jun 12, 2024 8:00 AM
Ubiquitech Software Corp (OTC:UBQU) Posts $624,585 Quarterly Revenue - Largest Quarter Since 2018 • UBQU • Jun 11, 2024 10:13 AM
Element79 Gold Corp Files for OTCQB Uplisting, Provides Financial Update • ELEM • Jun 11, 2024 9:25 AM